Renaissance Technologies
ALXN

Renaissance Technologies’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,147,521
Closed -$578M 4040
2021
Q2
$578M Sell
3,147,521
-180,600
-5% -$33.2M 0.72% 12
2021
Q1
$509M Sell
3,328,121
-785,583
-19% -$120M 0.63% 19
2020
Q4
$643M Sell
4,113,704
-643,539
-14% -$101M 0.7% 20
2020
Q3
$544M Buy
4,757,243
+278,000
+6% +$31.8M 0.54% 31
2020
Q2
$503M Buy
4,479,243
+715,741
+19% +$80.3M 0.43% 41
2020
Q1
$338M Buy
3,763,502
+32,358
+0.9% +$2.91M 0.33% 58
2019
Q4
$404M Buy
3,731,144
+881,477
+31% +$95.3M 0.31% 52
2019
Q3
$279M Buy
2,849,667
+1,207,125
+73% +$118M 0.24% 85
2019
Q2
$215M Buy
1,642,542
+840,742
+105% +$110M 0.19% 111
2019
Q1
$108M Buy
801,800
+420,700
+110% +$56.9M 0.1% 237
2018
Q4
$37.1M Buy
381,100
+313,200
+461% +$30.5M 0.04% 562
2018
Q3
$9.44M Buy
+67,900
New +$9.44M 0.01% 1400
2018
Q1
Sell
-178,800
Closed -$21.4M 3663
2017
Q4
$21.4M Sell
178,800
-263,400
-60% -$31.5M 0.02% 899
2017
Q3
$62M Buy
442,200
+229,900
+108% +$32.3M 0.07% 334
2017
Q2
$25.8M Sell
212,300
-148,642
-41% -$18.1M 0.03% 705
2017
Q1
$43.8M Buy
+360,942
New +$43.8M 0.06% 399
2015
Q4
Sell
-689,542
Closed -$108M 3496
2015
Q3
$108M Buy
689,542
+676,100
+5,030% +$106M 0.26% 53
2015
Q2
$2.43M Sell
13,442
-300,510
-96% -$54.3M 0.01% 1933
2015
Q1
$54.4M Buy
313,952
+161,400
+106% +$28M 0.12% 188
2014
Q4
$28.2M Sell
152,552
-53,600
-26% -$9.92M 0.07% 337
2014
Q3
$34.2M Sell
206,152
-39,400
-16% -$6.53M 0.09% 257
2014
Q2
$38.4M Buy
+245,552
New +$38.4M 0.09% 250